• Why We Need Clinical Trials For Lymphoma
  • My Long-Term Side Effects of Chemo
  • Sutro Says STRO-001 Wiped Out or Slowed Growth of Lymphoma and Myeloma in Animals
  • Intensifying Chemotherapy with Rituxan of Little Help to Advanced Hodgkins Lymphoma Patients, HD18 Trial Shows
  • Revlimid-Rituxan Combo Proves Effective Against Hard-to-Treat Non-Hodgkin’s Lymphomas, Trial Shows
  • FDA Grants Investigational New Drug Status to Combination of ACTR707 and Rituxan for Lymphoma
  • Advisory Committee Recommends That FDA Approve CTL019 for Treating Children with Leukemia
  • FDA Committee Recommends Approval of Mylotarg to Treat Newly Diagnosed AML
  • What It Took to Overcome Adversity with Positivity
  • Lymphoma Therapy Developer Kite Is Number 7 on MIT Technology Review’s List of 50 Smartest Companies
  • FDA Will Review Application Seeking Approval of Truxima for Same Indications as Rituxan
  • Potential Oral Therapy for Indolent Non-Hodgkin’s Lymphoma, Duvelisib, Shows Efficacy in Phase 2 Trial
  • Response to Kite’s CAR T-Cell Therapy in NHL Isn’t Dependent on Disease Factors, Researchers Say